Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.310
-0.080 (-5.76%)
At close: Feb 11, 2026, 4:00 PM EST
1.360
+0.050 (3.82%)
After-hours: Feb 11, 2026, 7:32 PM EST
Organigram Global Revenue
Organigram Global had revenue of 63.54M CAD in the quarter ending December 31, 2025, with 48.70% growth. This brings the company's revenue in the last twelve months to 279.99M, up 68.55% year-over-year. In the fiscal year ending September 30, 2025, Organigram Global had annual revenue of 259.18M with 62.15% growth.
Revenue (ttm)
279.99M CAD
Revenue Growth
+68.55%
P/S Ratio
0.86
Revenue / Employee
245,822 CAD
Employees
1,139
Market Cap
175.02M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 259.18M | 99.34M | 62.15% |
| Sep 30, 2024 | 159.84M | -1.80M | -1.11% |
| Sep 30, 2023 | 161.64M | 15.83M | 10.86% |
| Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
| Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
| Aug 31, 2020 | 86.80M | 6.38M | 7.94% |
| Aug 31, 2019 | 80.41M | 67.98M | 546.98% |
| Aug 31, 2018 | 12.43M | -377.00K | -2.94% |
| Aug 31, 2017 | 12.81M | 550.75K | 4.49% |
| Aug 31, 2016 | 12.26M | 11.27M | 1,142.07% |
| Aug 31, 2015 | 986.68K | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolus | 285.82M |
| Aurora Cannabis | 272.13M |
| Akebia Therapeutics | 225.07M |
| Canopy Growth | 203.04M |
| Lifecore Biomedical | 128.87M |
| Anika Therapeutics | 112.81M |
| Eton Pharmaceuticals | 70.32M |
| Journey Medical | 59.40M |
OGI News
- 8 hours ago - Organigram Global Is Now A Strong Buy - Seeking Alpha
- 1 day ago - Organigram Global Inc. (OGI:CA) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Organigram Reports First Quarter Fiscal 2026 Results - Business Wire
- 8 days ago - Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 - Business Wire
- 6 weeks ago - Organigram Extends Innovation Investment with Phylos - Business Wire
- 7 weeks ago - Organigram: Premium Pivot Signals Further Margin Expansion - Seeking Alpha
- 7 weeks ago - 3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III? - Seeking Alpha
- 2 months ago - Organigram Global Inc. (OGI:CA) Q4 2025 Earnings Call Transcript - Seeking Alpha